 | | PATHWAY: ko04810 | |
Entry |
|
Name |
Regulation of actin cytoskeleton |
Class |
Cellular Processes; Cell motility
|
Pathway map |
ko04810 | Regulation of actin cytoskeleton |

|
Other DBs |
|
Orthology |
K00889 | PIP5K; 1-phosphatidylinositol-4-phosphate 5-kinase [EC:2.7.1.68] |
K00921 | PIKFYVE, FAB1; 1-phosphatidylinositol-3-phosphate 5-kinase [EC:2.7.1.150] |
K00922 | PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] |
K02085 | APC; adenomatosis polyposis coli protein |
K02649 | PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta |
K03914 | F2R, PAR1; coagulation factor II (thrombin) receptor |
K03915 | BDKRB1; bradykinin receptor B1 |
K03916 | BDKRB2; bradykinin receptor B2 |
K03994 | C5; complement component 5 |
K03995 | C6; complement component 6 |
K03996 | C7; complement component 7 |
K03997 | C8A; complement component 8 subunit alpha |
K03998 | C8B; complement component 8 subunit beta |
K03999 | C8G; complement component 8 subunit gamma |
K04000 | C9; complement component 9 |
K04129 | CHRM1; muscarinic acetylcholine receptor M1 |
K04130 | CHRM2; muscarinic acetylcholine receptor M2 |
K04131 | CHRM3; muscarinic acetylcholine receptor M3 |
K04132 | CHRM4; muscarinic acetylcholine receptor M4 |
K04133 | CHRM5; muscarinic acetylcholine receptor M5 |
K04189 | CXCR4, CD184; C-X-C chemokine receptor type 4 |
K04275 | LPAR4, GPR23; lysophosphatidic acid receptor 4 |
K04289 | LPAR1, EDG2; lysophosphatidic acid receptor 1 |
K04291 | LPAR2, EDG4; lysophosphatidic acid receptor 2 |
K04346 | GNA12; guanine nucleotide-binding protein subunit alpha-12 |
K04347 | GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 |
K04357 | EGF; epidermal growth factor |
K04358 | FGF; fibroblast growth factor |
K04359 | PDGFA; platelet-derived growth factor subunit A |
K04362 | FGFR1, CD331; fibroblast growth factor receptor 1 [EC:2.7.10.1] |
K04363 | PDGFRA, CD140A; platelet-derived growth factor receptor alpha [EC:2.7.10.1] |
K04365 | BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] |
K04366 | RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] |
K04367 | MOS; proto-oncogene serine/threonine-protein kinase mos [EC:2.7.11.1] |
K04368 | MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] |
K04369 | MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] |
K04392 | RAC1; Ras-related C3 botulinum toxin substrate 1 |
K04393 | CDC42; cell division control protein 42 |
K04438 | CRK, CRKII; C-crk adapter molecule crk |
K04513 | RHOA; Ras homolog gene family, member A |
K04639 | GNA13; guanine nucleotide-binding protein subunit alpha-13 |
K05089 | PDGFRB, CD140B; platelet-derived growth factor receptor beta [EC:2.7.10.1] |
K05093 | FGFR2, CD332; fibroblast growth factor receptor 2 [EC:2.7.10.1] |
K05094 | FGFR3, CD333; fibroblast growth factor receptor 3 [EC:2.7.10.1] |
K05095 | FGFR4, CD334; fibroblast growth factor receptor 4 [EC:2.7.10.1] |
K05450 | PDGFC_D; platelet derived growth factor C/D |
K05627 | BAIAP2, IRSP53; BAI1-associated protein 2 |
K05692 | ACTB_G1; actin beta/gamma 1 |
K05699 | ACTN1_4; actinin alpha 1/4 |
K05718 | ITGAL, CD11a; integrin alpha L |
K05719 | ITGB1, CD29; integrin beta 1 |
K05720 | FGD1; FYVE, RhoGEF and PH domain containing 1 |
K05722 | FGD3; FYVE, RhoGEF and PH domain containing 3 |
K05726 | BCAR1, CAS; breast cancer anti-estrogen resistance 1 |
K05729 | ARHGEF6, PIXA; Rho guanine nucleotide exchange factor 6 |
K05730 | VAV; guanine nucleotide exchange factor VAV |
K05731 | TIAM1; T-lymphoma invasion and metastasis-inducing protein 1 |
K05732 | ARHGAP35, GRLF1; glucocorticoid receptor DNA-binding factor 1 |
K05737 | GIT1; G protein-coupled receptor kinase interactor 1 |
K05742 | SLC9A1, NHE1; solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
K05745 | DIAPH3, DRF3; diaphanous 3 |
K05748 | WASF2; WAS protein family, member 2 |
K05749 | CYFIP; cytoplasmic FMR1 interacting protein |
K05750 | NCKAP1, NAP125; NCK-associated protein 1 |
K05752 | C3ORF10, HSPC300; chromosome 3 open reading frame 10 |
K05753 | WASF1; WAS protein family, member 1 |
K05754 | ARPC5; actin related protein 2/3 complex, subunit 5 |
K05755 | ARPC4; actin related protein 2/3 complex, subunit 4 |
K05756 | ARPC3; actin related protein 2/3 complex, subunit 3 |
K05757 | ARPC1A_B; actin related protein 2/3 complex, subunit 1A/1B |
K05758 | ARPC2; actin related protein 2/3 complex, subunit 2 |
K05764 | TMSB4; thymosin, beta 4 |
K05767 | IQGAP2_3; Ras GTPase-activating-like protein IQGAP2/3 |
K05769 | ARHGEF4_29, ASEF1_2; Rho guanine nucleotide exchange factor 4/29 |
K06269 | PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16] |
K06270 | PPP1R12A, MYPT1; protein phosphatase 1 regulatory subunit 12A |
K06461 | ITGAM, CD11b; integrin alpha M |
K06462 | ITGAX, CD11c; integrin alpha X |
K06464 | ITGB2, CD18; integrin beta 2 |
K06476 | ITGA2B, CD41; integrin alpha 2B |
K06480 | ITGA1, CD49a; integrin alpha 1 |
K06481 | ITGA2, CD49b; integrin alpha 2 |
K06482 | ITGA3, CD49c; integrin alpha 3 |
K06483 | ITGA4, CD49d; integrin alpha 4 |
K06484 | ITGA5, CD49e; integrin alpha 5 |
K06485 | ITGA6, CD49f; integrin alpha 6 |
K06487 | ITGAV, CD51; integrin alpha V |
K06493 | ITGB3, CD61; integrin beta 3 |
K06524 | ITGAE, CD103; integrin alpha E |
K06525 | ITGB4, CD104; integrin beta 4 |
K06583 | ITGA7; integrin alpha 7 |
K06584 | ITGA8; integrin alpha 8 |
K06585 | ITGA9; integrin alpha 9 |
K06586 | ITGA10; integrin alpha 10 |
K06587 | ITGA11; integrin alpha 11 |
K06594 | ITGAD, CD11d; integrin alpha D |
K07532 | ARHGEF12, LARG; Rho guanine nucleotide exchange factor 12 |
K07827 | KRAS, KRAS2; GTPase KRas |
K07829 | RRAS; Ras-related protein R-Ras |
K07830 | RRAS2, TC21; Ras-related protein R-Ras2 |
K07831 | MRAS; Ras-related protein M-Ras |
K07860 | RAC2; Ras-related C3 botulinum toxin substrate 2 |
K07861 | RAC3; Ras-related C3 botulinum toxin substrate 3 |
K08390 | LPAR5, GPR92; lysophosphatidic acid receptor 5 |
K08845 | ARAF, ARAF1; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] |
K10031 | CXCL12; C-X-C motif chemokine 12 |
K10351 | MYL2; myosin regulatory light chain 2 |
K10352 | MYH9s; myosin heavy chain 9/10/11/14 |
K12329 | PPP1R12B, MYPT2; protein phosphatase 1 regulatory subunit 12B |
K12330 | ARHGEF1; Rho guanine nucleotide exchange factor 1 |
K12753 | MYL5; myosin regulatory light chain 5 |
K12754 | MYL7; myosin regulatory light chain 7 |
K12755 | MYL9; myosin regulatory light chain 9 |
K12756 | MYL10; myosin regulatory light chain 10 |
K12757 | MYL12; myosin regulatory light chain 12 |
K12758 | MYLPF; fast skeletal myosin light chain 2 |
K13708 | DOCK1; dedicator of cytokinesis protein 1 |
K13710 | ARHGEF7, PIXB; Rho guanine nucleotide exchange factor 7 |
K16848 | IQGAP1; Ras GTPase-activating-like protein IQGAP1 |
K17260 | ACTR2, ARP2; actin-related protein 2 |
K17386 | PDGFB; platelet-derived growth factor subunit B |
K17457 | PPP1R12C, MBS85; protein phosphatase 1 regulatory subunit 12C |
K18496 | FGF1; fibroblast growth factor 1 |
K18497 | FGF2; fibroblast growth factor 2 |
K18584 | ACTR3, ARP3; actin-related protein 3 |
K22428 | FGF23; fibroblast growth factor 23 |
K22429 | FGF21; fibroblast growth factor 21 |
K22603 | FGF19; fibroblast growth factor 19 |
K23612 | WASL; neural Wiskott-Aldrich syndrome protein |
K26108 | RGCC, RGC32; regulator of cell cycle RGCC |
K27976 | CYRI, FAM49; CYFIP-related Rac1 interactor |
|
Compound |
C00681 | 1-Acyl-sn-glycerol 3-phosphate |
C04637 | 1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
C11554 | 1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate |
|
Reference |
|
Authors |
Burridge K, Wennerberg K. |
Title |
Rho and Rac take center stage. |
Journal |
|
Reference |
|
Authors |
Schmitz AA, Govek EE, Bottner B, Van Aelst L. |
Title |
Rho GTPases: signaling, migration, and invasion. |
Journal |
|
Reference |
|
Authors |
Takai Y, Sasaki T, Matozaki T. |
Title |
Small GTP-binding proteins. |
Journal |
|
Reference |
|
Authors |
Pollard TD. |
Title |
The cytoskeleton, cellular motility and the reductionist agenda. |
Journal |
|
Reference |
|
Authors |
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. |
Title |
Cell migration: integrating signals from front to back. |
Journal |
|
Reference |
|
Authors |
Sastry SK, Burridge K. |
Title |
Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. |
Journal |
|
Reference |
|
Authors |
Fukata M, Nakagawa M, Kuroda S, Kaibuchi K. |
Title |
Cell adhesion and Rho small GTPases. |
Journal |
J Cell Sci 112 ( Pt 24):4491-500 (1999) |
Related pathway |
|
|
|